February 11, 2009 4:40 PM
- Text
Genes For Breast Cancer? Look To Dad
(CBS/AP)
A deadly gene's path can hide in a family tree when a woman has few aunts and older sisters, making it appear that her breast cancer struck out of nowhere when it really came from Dad.
A new study suggests thousands of young women with breast cancer — an estimated 8,000 a year in the U.S. — aren't offered testing to identify faulty genes and clarify their medical decisions.
Guidelines used by insurance companies to decide coverage for genetic testing should change to reflect the findings, said study co-author Dr. Jeffrey Weitzel of City of Hope Cancer Center in Duarte, Calif. Testing can cost more than $3,000.
"Interestingly, it's about Dad," Weitzel said. Half of genetic breast cancers are inherited from a woman's father, not her mother. But unless Dad has female relatives with breast cancer, the faulty gene may have been passed down silently, without causing cancer. (Men can get genetic breast cancer, too, but it's not common.)
Weitzel said doctors often overlook the genetic risk from the father's side of the family.
"Knowing about your genetic history, knowing if you carry these genes is vitally important," The Early Show medical correspondent Dr. Emily Senay said, "because it will dictate how doctors go about treating you and how they go about monitoring you and even preventing the development of breast and ovarian cancer. This is critical information."
The study, appearing in Wednesday's Journal of the American Medical Association, looked at the genetic test results from 306 women diagnosed with breast cancer before age 50.
None of the cancer patients in the study had a family history of breast or ovarian cancer.
Among the women with plenty of female relatives, 5.2 percent had BRCA gene mutations ("BR" for breast, "CA" for cancer"). But among those with few sisters and aunts older than 45 (when breast cancer would be likely to appear), almost 14 percent had mutations of the genes BRCA1 or BRCA2. That suggests that these cancer patients were unaware of their genetic mutations because there were so few women in the family to signal a cancer risk.
The researchers defined few female relatives as fewer than two on either the father's or mother's side of the family.
Women who were adopted and don't know their family medical history should be aware of the findings, Weitzel said. Women whose female relatives died young before breast cancer had time to show up also are affected.
When such a woman gets breast cancer before age 50, she should get a genetic test, said Dr. Noah Kauff, a cancer geneticist at Memorial Sloan-Kettering Cancer Center in New York. That would help her decide whether to have the unaffected breast or her ovaries removed to prevent more cancer. Kauff was not involved in the research, but wrote an accompanying editorial.
"The study allows physicians and patients to make an argument to insurance carriers that, although there's not a family history of breast cancer, it's still reasonable to test and it should be a covered benefit," Kauff said.
Genetic testing helps a woman choose her next medical steps. A woman with breast cancer who has a BRCA gene mutation has a four times greater risk of developing cancer in the other breast and a 10 times greater risk of ovarian cancer than does a woman with breast cancer who has no BRCA gene mutation.
"It increases the risk so much, doctors will recommend that women undergo a preventive or prophylactic mastectomy. They may even recommend ovary removal to prevent the development of cancer," Dr. Senay said. "So yes, it has a real impact on the decisions made about the woman's health" — such as the efficacy of alternative treatements, like drug therapy or monitoring with annual MRI tests.
Testing the genes of more women would cost more money, but Weitzel said that won't add significantly to health care costs and will prevent cancer in some of the women.
The study also showed that three commonly used predictive models don't accurately estimate the genetic breast cancer risk for women without a family history of cancer. The American Cancer Society recently based its recommendation for annual MRIs on risk assessments from the predictive models.
A new study suggests thousands of young women with breast cancer — an estimated 8,000 a year in the U.S. — aren't offered testing to identify faulty genes and clarify their medical decisions.
Guidelines used by insurance companies to decide coverage for genetic testing should change to reflect the findings, said study co-author Dr. Jeffrey Weitzel of City of Hope Cancer Center in Duarte, Calif. Testing can cost more than $3,000.
"Interestingly, it's about Dad," Weitzel said. Half of genetic breast cancers are inherited from a woman's father, not her mother. But unless Dad has female relatives with breast cancer, the faulty gene may have been passed down silently, without causing cancer. (Men can get genetic breast cancer, too, but it's not common.)
Weitzel said doctors often overlook the genetic risk from the father's side of the family.
"Knowing about your genetic history, knowing if you carry these genes is vitally important," The Early Show medical correspondent Dr. Emily Senay said, "because it will dictate how doctors go about treating you and how they go about monitoring you and even preventing the development of breast and ovarian cancer. This is critical information."
The study, appearing in Wednesday's Journal of the American Medical Association, looked at the genetic test results from 306 women diagnosed with breast cancer before age 50.
None of the cancer patients in the study had a family history of breast or ovarian cancer.
Among the women with plenty of female relatives, 5.2 percent had BRCA gene mutations ("BR" for breast, "CA" for cancer"). But among those with few sisters and aunts older than 45 (when breast cancer would be likely to appear), almost 14 percent had mutations of the genes BRCA1 or BRCA2. That suggests that these cancer patients were unaware of their genetic mutations because there were so few women in the family to signal a cancer risk.
The researchers defined few female relatives as fewer than two on either the father's or mother's side of the family.
Women who were adopted and don't know their family medical history should be aware of the findings, Weitzel said. Women whose female relatives died young before breast cancer had time to show up also are affected.
When such a woman gets breast cancer before age 50, she should get a genetic test, said Dr. Noah Kauff, a cancer geneticist at Memorial Sloan-Kettering Cancer Center in New York. That would help her decide whether to have the unaffected breast or her ovaries removed to prevent more cancer. Kauff was not involved in the research, but wrote an accompanying editorial.
"The study allows physicians and patients to make an argument to insurance carriers that, although there's not a family history of breast cancer, it's still reasonable to test and it should be a covered benefit," Kauff said.
Genetic testing helps a woman choose her next medical steps. A woman with breast cancer who has a BRCA gene mutation has a four times greater risk of developing cancer in the other breast and a 10 times greater risk of ovarian cancer than does a woman with breast cancer who has no BRCA gene mutation.
"It increases the risk so much, doctors will recommend that women undergo a preventive or prophylactic mastectomy. They may even recommend ovary removal to prevent the development of cancer," Dr. Senay said. "So yes, it has a real impact on the decisions made about the woman's health" — such as the efficacy of alternative treatements, like drug therapy or monitoring with annual MRI tests.
Testing the genes of more women would cost more money, but Weitzel said that won't add significantly to health care costs and will prevent cancer in some of the women.
The study also showed that three commonly used predictive models don't accurately estimate the genetic breast cancer risk for women without a family history of cancer. The American Cancer Society recently based its recommendation for annual MRIs on risk assessments from the predictive models.
Popular Now in Health
- Cancer drug reverses Alzheimer's in mice: Study
- Marijuana-smoking motorists twice as likely to crash
- 4.5 million Americans over 50 have artificial knees
- Skin cancer self-exam: What to look for (PHOTOS)
- Norovirus outbreak hits Rider University in N.J
- America's pets also have an obesity epidemic
- Things You Didn't Know About Your Penis
- America's sodium problem: Not from salty snacks?
- PICTURES: 15 Shocking Sexual Fetishes
- Caffeine inhalers - the next club drug?
- Let's Move! campaign turns 2 today: Is it working?
- Chinese mom gives birth to 15-pound baby
- John Dye Dies: What Killed "Angel" Star?
- Woman spotlights uterus didelphys on talk show
- Christina Hendricks: Too Big for Hollywood?
- 8 Tips For Losing Weight After Pregnancy
- Measles patient at Super Bowl prompts health alert
Latest CBS News Headlines
on Facebook
on CBS News
- Holliday leads 76ers past short-handed Cavs 99-84
- Nuggets upend Pacers 113-109
- Griffin, Paul lead Clippers over Bobcats 111-86
- Whitney Houston died in Beverly Hills hotel room
on Facebook
- Adele sings a cappella for Anderson Cooper
- Occupy protestors kicked out of CPAC
- CPAC: Will Sarah Palin spring a surprise?
- Beyonce and Jay-Z post first photos of Blue Ivy Carter
on CBS News






